CD33
Myeloid cell surface antigen CD33
Also known as: CD33_HUMAN, FLJ00391, p67, SIGLEC-3, SIGLEC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20138
- Gene
- CD33
- Ensembl
- ENSG00000105383
- Chromosome
- 19
- Canonical length
- 364 aa
- Protein class
- CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein phosphatase binding activity; protein tyrosine phosphatase activator activity; and sialic acid binding activity. Involved in several processes, including immune response-regulating signaling pathway; negative regulation of cytokine production; and negative regulation of monocyte activation. Located in Golgi apparatus; external side of plasma membrane; and peroxisome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>P20138|CD33
1 MPLLLLLPLL WAGALAMDPN FWLQVQESVT VQEGLCVLVP CTFFHPIPYY DKNSPVHGYW
61 FREGAIISRD SPVATNKLDQ EVQEETQGRF RLLGDPSRNN CSLSIVDARR RDNGSYFFRM
121 ERGSTKYSYK SPQLSVHVTD LTHRPKILIP GTLEPGHSKN LTCSVSWACE QGTPPIFSWL
181 SAAPTSLGPR TTHSSVLIIT PRPQDHGTNL TCQVKFAGAG VTTERTIQLN VTYVPQNPTT
241 GIFPGDGSGK QETRAGVVHG AIGGAGVTAL LALCLCLIFF IVKTHRRKAA RTAVGRNDTH
301 PTTGSASPKH QKKSKLHGPT ETSSCSGAAP TVEMDEELHY ASLNFHGMNP SKDTSTEYSE
361 VRTQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD33 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 31 nTPM
- spleen: 23 nTPM
- lung: 12 nTPM
- appendix: 11 nTPM
- lymph node: 9.5 nTPM
- adipose tissue: 7.4 nTPM
Single-cell type
- kupffer cells: 196 nCPM
- hofbauer cells: 121 nCPM
- monocytes: 79 nCPM
- cdc: 69 nCPM
- monocyte progenitors: 54 nCPM
- macrophages: 53 nCPM
Immune cell
- myeloid DC: 214 nTPM
- classical monocyte: 167 nTPM
- intermediate monocyte: 122 nTPM
- total PBMC: 78 nTPM
- non-classical monocyte: 58 nTPM
- neutrophil: 21 nTPM
Brain region
- white matter: 7.6 nTPM
- medulla oblongata: 5.4 nTPM
- choroid plexus: 5 nTPM
- thalamus: 4.8 nTPM
- pons: 4.1 nTPM
- spinal cord: 3.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.14
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell-cell adhesion
- cell-cell signaling
- Fc-gamma receptor signaling pathway
- immune response-inhibiting signal transduction
- negative regulation of cell population proliferation
- negative regulation of interleukin-1 beta production
- negative regulation of interleukin-8 production
- negative regulation of monocyte activation
- negative regulation of tumor necrosis factor production
- positive regulation of protein secretion
- signal transduction
Molecular functions
- carbohydrate binding
- protein phosphatase binding
- protein tyrosine phosphatase activator activity
- sialic acid binding
- signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD33 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD33 as an antibody target. Whether an autoantibody or antibody against CD33 could matter depends on whether native CD33 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD33 is annotated at the cell surface, where native CD33 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD33 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...